<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940817-2-00057</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> During EPA's consideration of the 1990 Ethyl submission,  <!-- PJG 0012 frnewline --> EPA's Office of Research and Development (ORD) conducted a  <!-- PJG 0012 frnewline --> manganese inhalation risk assessment based on the available data  <!-- PJG 0012 frnewline --> which found that because of ``the considerable uncertainties and  <!-- PJG 0012 frnewline --> data gaps in the available information *&blank;*&blank;* it is not possible  <!-- PJG 0012 frnewline --> *&blank;*&blank;* to conclude definitively that the increased use of MMT as a  <!-- PJG 0012 frnewline --> fuel additive will (or will not) increase public health risk.'' <FOOTCITE>2</FOOTCITE>   <!-- PJG 0012 frnewline --> (EPA also investigated potential hazards associated with water  <!-- PJG 0012 frnewline --> contamination resulting from accidental spills or leakages of  <!-- PJG 0012 frnewline --> pure MMT and concluded that spills or leaks, if they occurred,  <!-- PJG 0012 frnewline --> are likely to be contained and therefore would not pose a human  <!-- PJG 0012 frnewline --> health risk due to groundwater contamination. However, data  <!-- PJG 0012 frnewline --> available to EPA are insufficient to determine whether spills and  <!-- PJG 0012 frnewline --> leaks could affect exposure to benthic organisms.)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <FOOTNOTE> <FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> 2 <!-- PJG /ITAG -->  </FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> See ``Comments on the Use of Methylcyclopentadienyl Manganese Tricarbonyl in Unleaded Gasoline'', Docket A&hyph;90&hyph;16. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </FOOTNOTE>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Additionally, in order to obtain assistance in describing  <!-- PJG 0012 frnewline --> information needed to improve its manganese health risk  <!-- PJG 0012 frnewline --> assessment (and also to improve its environmental hazard  <!-- PJG 0012 frnewline --> identification of issues associated with MMT itself), EPA, in  <!-- PJG 0012 frnewline --> conjunction with the National Institute of Environmental Health  <!-- PJG 0012 frnewline --> Sciences, conducted a Manganese/MMT Symposium and Workshop on  <!-- PJG 0012 frnewline --> March 12&hyph;15, 1991. The conference allowed the Agency to solicit  <!-- PJG 0012 frnewline --> scientific information from invited extramural scientists  <!-- PJG 0012 frnewline --> reflecting a wide range of scientific disciplines. Invited  <!-- PJG 0012 frnewline --> participants included representatives of Ethyl Corporation, the  <!-- PJG 0012 frnewline --> Environmental Defense Fund, the Centers for Disease Control, the  <!-- PJG 0012 frnewline --> U.S. Food and Drug Administration and Environment Canada. A  <!-- PJG 0012 frnewline --> summary of the workshop discussions was provided to each  <!-- PJG 0012 frnewline --> participant and the information obtained from this meeting was  <!-- PJG 0012 frnewline --> also used by EPA to prepare a report on prioritized research  <!-- PJG 0012 frnewline --> needed for improving its manganese inhalation risk assessment. <FOOTCITE>3</FOOTCITE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <FOOTNOTE> <FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> 3 <!-- PJG /ITAG -->  </FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> Preuss, P.W. (1991) ORD Document on Information Needed to Improve the Risk Characterization of Manganese Tetraoxide (Mn <!-- PJG /ITAG -->  <!-- PJG ITAG l=28 g=5 f=2 --> 3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=28 g=1 f=1 --> O <!-- PJG /ITAG -->  <!-- PJG ITAG l=28 g=5 f=2 --> 4 <!-- PJG /ITAG -->  <!-- PJG ITAG l=28 g=1 f=1 --> ) and Methylcyclopentadienyl Manganese Tricarbonyl, December 12, 1991 (memorandum to Richard Wilson). Washington, DC: U.S. Environmental Protection Agency, Office of Research and Development; December 16, 1991. For further information the reader is referred to Air Docket A&hyph;93&hyph;26, II&hyph;A&hyph;16. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> </FOOTNOTE>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> EPA raised the issue of potential health effects associated  <!-- PJG 0012 frnewline --> with manganese exposure as a concern in its January 1992 denial,  <!-- PJG 0012 frnewline --> but did not base its decision on this concern because the Agency  <!-- PJG 0012 frnewline --> concluded that the uncertainties regarding hydrocarbon emissions  <!-- PJG 0012 frnewline --> increases prevented EPA from making the requisite ``cause or  <!-- PJG 0012 frnewline --> contribute'' determination concerning effects on regulated  <!-- PJG 0012 frnewline --> emissions.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> On February 13, 1992, Ethyl filed a petition for review of  <!-- PJG 0012 frnewline --> the January 8, 1992 waiver denial decision in the United States  <!-- PJG 0012 frnewline --> Court of Appeals for the District of Columbia Circuit. EPA and  <!-- PJG 0012 frnewline --> Ethyl subsequently entered discussions concerning a possible  <!-- PJG 0012 frnewline --> settlement of the court case. In the context of those  <!-- PJG 0012 frnewline --> discussions, Ethyl submitted to the Agency new emissions test  <!-- PJG 0012 frnewline --> data developed by Ethyl since the denial decision.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            